During the past decade, GENRE conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "GENRE" are "Barrett Esophagus Adenocarcinoma" (1 trials), "Cancer" (1 trials), "Colorectal Adenoma" (1 trials), "Critical Care" (1 trials) and "Haematologic Disease (Cancer)" (1 trials). Many other conditions were trialed in "GENRE" in a lesser frequency.

Most popular intervention types in "GENRE" are "Other" (3 trials), "Procedure" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Antibiotic de-escalation" (1 trials), "Complete endoscopic resection at Day 1 and months 2, 4, 6 8 and month 10." (1 trials), "Endoscopic resection" (1 trials), "Endoscopic resection at month 2 and month 4" (1 trials) and "Interviews with coach" (1 trials). Other intervention names were less common.

The vast majority of trials in "GENRE" are 6 trials for "All" genders.

Currently, there are NaN active trials in "GENRE". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in GENRE, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in GENRE, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".